article thumbnail

Drug Formulation In-Depth Focus 2022

European Pharmaceutical Review

In this short article, René Holm, Professor in pharmaceutical physical chemistry at the University of Southern Denmark, provides a few examples of how a rational formulation design for a cyclodextrin solution can be defined for some important parameters. Solving the taxing problems of taxanes?

article thumbnail

2022 IDstewardship Year End Review

IDStewardship

In this article we do a quick run down on IDstewardship for the end of 2022. . Article Posted 26 December 2022. As we all take a breath before heading into a new year in 2023, this article is provided as a look back and checkpoint in the life of IDstewardship.com, LearnAntibiotics.com, and the IDstewardship social media profiles.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A List Of Antimicrobial Stewardship and Infectious Diseases Conferences and Meetings

IDStewardship

BCPS, BCIDP Article Posted May 2023 There are many infectious diseases conferences and meetings that take place around the world each year. On this webpage, a list of antimicrobial stewardship and infectious diseases conferences and meetings is provided. List Composed By: Timothy P. Gauthier, Pharm.D.,

article thumbnail

Intratumoural viral delivery improves glioblastoma survival

European Pharmaceutical Review

Novel device opens blood-brain barrier to deliver chemotherapy Intratumoural delivery The current trial was designed to evaluate the combination of intratumoural DNX-2401 followed by intravenous pembrolizumab therapy. An increase in PD-1 checkpoint expression was seen following the treatment via intratumoural delivery.

article thumbnail

Could personalised mRNA vaccine be first for cancer?

European Pharmaceutical Review

Article: Key developments: mRNA vaccines and therapeutics … Method and results of the Phase I trial The intravenously delivered mRNA vaccine was safe and generated substantial neoantigen-specific T cells in half of unselected patients with resectable PDAC, the study reported.

article thumbnail

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

pharmaphorum

Chemotherapy still accounted for 72.6% Chemotherapy still plays a significant role in oncology treatment, accounting for 72.6% While all of the top ten best-selling oncology drugs in the US in 2019 were innovative therapies, four out of the top ten best-selling oncology drugs in China were for conventional chemotherapy. “In

article thumbnail

Drug approval roundup – May/June 2024

European Pharmaceutical Review

Immunotherapy in oncology “The addition of pembrolizumab to chemotherapy represents a new frontline therapeutic option for patients with primary advanced or recurrent endometrial carcinoma” Moreover, last week saw US regulatory approval of a combination treatment for endometrial cancer : KEYTRUDA (pembrolizumab) plus chemotherapy.